Xpert TB Test More Effective Than Traditional Detection Methods, Study Shows

Center for Global Health Policy’s “Science Speaks”: Large-scale study underscores value of routine Xpert testing on TB, MDR-TB case finding
Antigone Barton, senior editor and writer of “Science Speaks,” discusses the findings of a recently published study conducted in India showing the Xpert molecular TB test is more effective than traditional microscopic testing at detecting the bacteria and determining whether the strain is drug resistant (5/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.